Quick Links
Authorised and regulated by the Financial Services Authority
Weekly Report
The weekly report is published on Fridays to all newsletter subscribers. The report comprises of three articles which will provide you with our analysis of the markets. The report also includes three trade recommendations picked by our Research Team. This report is available for free to non-Blue Index clients, all you need to do is create a Member account in order to receive this report directly to your inbox every week.
China instigates increase in volitility
The various indices that measure stockmarket volatility have been drifting down for the last three years, but have risen a couple of times this year. Again this week they surged as a fall in the Chinese market provided more ammunition for the bears, but it was not enough to hold back the tide of buying.
S&P closes in on it's all time high
Last week, equities around the world were racing ahead with the feeling that the S&P 500 would at long last surpass its year 2000 high. Although it is near the best historic close at 1527, the actual intra-day high came in at 1552. This area is crucial as there may be plenty of short stops that need to be cleared before there are no more buyers to keep the rally going.
Dow Jones hits yet another new high
This week the Dow Jones hit its twenty third new high since it breached the year 2000 peak last October, and at the time many commentators were saying that we were not in a proper bull market because the wider S&P 500 index was still way below its own peak. The interesting point now is that the S&P has raced up and is just 27 points away from its own all time high at 1527, and one wonders if there are plenty of short stops positioned around here.
The mining sector joins the M&A merry go round
This week we are highlighting some of the major stories in a sector for which we have had a long term bullish view on the back of the expectation of significantly higher commodity prices to come. We take a look at the Alcoa bid for Alcan, the outlook for the UK mining majors, and give a brief outline of the uranium market.
Part 2 of 2: The Pharmaceuticals Sector
This week we take a look at the fundamental and technical outlook for Pfizer, the world’s largest drug company, and the two big players in the UK, Glaxo Smithkline and Astra Zeneca.All three stocks provide high volatility and have given opportunities for CFD traders on both the long and the short side over the last year
